In breast cancer models, however, EGFR overexpression alone usually does not constitute efficient transformation and tumorigenesis while co-expression with the non-receptor kinase c-Src dramatically increases tumorigenesis 7–9. This evidence concerns the gene SRC and breast carcinoma.